Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Using Biomarkers to Detect Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Management

The Effects of Cancer on Family Life

Insights into Oncofertility

Secondary Brain Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Living with Cancer Pain

Acidosis and Tumor Progression

See more featured articles »

TARDIS: The Improved Method of Detecting Breast Cancer

Transforming Cancer Care through Genomic Testing

Is Cancer a Metabolic Disorder?

What is Cancer?

Cancer Prevention: Lowering your Risk

Why are Cancer Cell Lines Useful?

Cancer Symptoms

Metastatic Migration in Cancer may be Influenced by Metabolism

Overview of Cell Viability and Cytotoxicity

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What is Cancer of Unknown Primary?

Cancer Pathophysiology

What is Merkel Cell Carcinoma?

Cutaneous Manifestations of Internal Malignancy

Caring for a Loved One with Cancer

What is the Tumor Microenvironment?

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Research

Insight into Cancer Vaccines

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Targeted Cancer Therapies

Cancer Glossary

Cancer Prognosis

Extracellular Vesicles as Floating Cancer Biomarkers

Hypoxia Markers and Their Importance

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Pain Management

Hot vs Cold: the differences between tumor types

What Role do Biobanks Play in Cancer Research?

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Pain

What is Tumorigenesis?

Cancer Screening Considerations: Balancing the Benefits and Risks

Secondary Lung Cancer

Cancer Epidemiology

The Cancer Cell Surface Proteome as a Therapeutic Target

Myc Mutations and Cancer

What Causes Cancer?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Investigating the Molecular Mechanisms of Cancer

The Biochemistry of Breast Cancer Screening

Cancer History

Pediatric Cancer

Cancer Diagnosis

CDK9 and Cancer

What is Immunochemotherapy?

British Pioneers in Cancer Biology

Cancer Classification

Latest Cancer News and Research

New nanomaterial enhances bioimaging and targeted cancer drug delivery

The Nanomedicine and Nanotoxicology Group (GNano) at the University of São Paulo's São Carlos Institute of Physics (IFSC-USP) in Brazil has discovered a way to transform hydroxyapatite, a bioceramic material, into a nanoparticle with enhanced intrinsic luminescence.

18 Mar 2026

New data hub aims to advance alternatives to animal testing

A research team at NYU Langone Health and Sage Bionetworks has been awarded a $25 million grant to establish the data hub and coordinating center for the National Institutes of Health's Complement-Animal Research in Experimentation (Complement-ARIE) program.

18 Mar 2026

Blocking a single protein could make hidden HPV-positive tumors vulnerable to treatment

A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows certain head and neck cancers to hide from the immune system, a discovery that could change how some of the most treatment resistant tumors are approached.

18 Mar 2026

New pathway explains poor response to bladder cancer immunotherapy

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well to immunotherapy.

18 Mar 2026

New mechanism drives adverse tumor remodeling during breast cancer progression

A research group led by Professor Cecilia Sahlgren at Åbo Akademi University (Finland) and the InFLAMES Research Flagship has identified a new mechanism directing the adverse remodeling of tumor tissue during breast cancer progression.

18 Mar 2026

Stopping GLP-1 treatment linked to increase in risk of major cardiovascular events

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits.

18 Mar 2026

Precise application of radio waves could help counter neurological conditions

A new study found that precise application of radio waves can change the activity of brain cells in ways that could counter neurological conditions.

18 Mar 2026

Cancer cells rely on glutathione as fuel for growth

Researchers discovered an antioxidant, glutathione, that cancer cells appear to be "addicted to" as fuel, opening new pathways for investigation and a potential drug that can restrict the way tumors use this nutrient.

18 Mar 2026

Thymus health in adults linked to longer life and disease risk

Two new studies from investigators at Mass General Brigham challenge a decades-old assumption that the thymus, an organ best known for its role in establishing immune function in childhood, becomes irrelevant in adulthood.

18 Mar 2026

Mitochondrial-proteasome-heme axis rewires T cell fate and weakens cancer therapy

Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed.

18 Mar 2026

Gut-derived blood markers may help predict who develops coronary heart disease

Researchers used five prospective cohorts from the US and China to identify circulating gut microbiota-related metabolites linked to future coronary heart disease, then tested the findings through discovery, in silico validation, and targeted quantitative validation. The study ultimately highlighted nine metabolites associated with incident CHD, supporting a potential role for microbial metabolism in heart disease risk while not proving causation

18 Mar 2026

Protein targeted by cancer drugs may help the body fight influenza

A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX).

18 Mar 2026

Impact of ban and ordinances against indoor smoking in eating, drinking establishments

To reduce the adverse health effects associated with exposure to second-hand smoke, Japan fully enforced the Revised Health Promotion Law in April 2020, introducing a nationwide indoor smoking ban in restaurants and similar hospitality establishments.

18 Mar 2026

Muscle-repairing macrophages trigger heterotopic ossification in mice

We have identified a macrophage population "Mrep" that plays an essential role in muscle repair. However, in Fibrodysplasia ossificans progressiva (FOP), Mrep functions as a pathogenic cell that triggers heterotopic ossification.

18 Mar 2026

New approach tracks metabolic fingerprints of tuberculosis-infected human cells

Researchers from King's College London and the University of Surrey have developed a new technique to measure the content of individual human cells infected with bacteria that model tuberculosis – and it is already revealing biological changes that conventional analysis would miss.

18 Mar 2026

Combination therapy shows promise for leptomeningeal metastasis in breast cancer

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM.

18 Mar 2026

Aptamer Group launches targeted radiopharmaceutical program

Aptamer Group plc, the developer of next‑generation synthetic binders for the life sciences industry, today announced the launch of a new targeted radiopharmaceutical program in collaboration with Radiopharmium Ltd, a UK-based specialist consultancy in radiopharmaceutical development.

From Aptamer Group 18 Mar 2026

New nanoparticle therapy overcomes T cell exhaustion in solid tumors

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including common variants such as cancers of the breast, liver and colon.

18 Mar 2026

New approach developed to visualize proteins at unprecedented scale and sensitivity

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest questions.

18 Mar 2026

Newly identified protein regulates lysosome positioning and cellular metabolism

Lysosomes are the control centers for the metabolism of cells and tissues, including the brain. They break down defective proteins and other macromolecules into their basic building blocks.

18 Mar 2026